Lymphoid proliferations in people with HIV/AIDS associated with infection by other viral agents
| . | HIV . | EBV (Latency) . | KSHV . |
|---|---|---|---|
| Hodgkin lymphoma | + | + (II) | — |
| BL-plasmacytoid | + | −/+ (I) | — |
| DLBCL-IBL plasmacytoid | + | + (II) | — |
| PEL and its solid variants | + | + (I) | + |
| PBL of the oral cavity type | + | +/− (I) | — |
| MCD-associated LBCL | + | — | + |
| MCD | + | — | + |
| . | HIV . | EBV (Latency) . | KSHV . |
|---|---|---|---|
| Hodgkin lymphoma | + | + (II) | — |
| BL-plasmacytoid | + | −/+ (I) | — |
| DLBCL-IBL plasmacytoid | + | + (II) | — |
| PEL and its solid variants | + | + (I) | + |
| PBL of the oral cavity type | + | +/− (I) | — |
| MCD-associated LBCL | + | — | + |
| MCD | + | — | + |
+, positive in 100% of cases; −, negative in 100% of cases; −/+, positive in less than 50% of cases; +/−, positive in more than 50% of cases; IBL, immunoblastic lymphoma.